Literature DB >> 24165625

Long-term sensory recovery of nipple-areola complex following superolateral pedicled reduction mammaplasty.

Benedetto Longo1, Antonella Campanale, Alessio Farcomeni, Fabio Santanelli.   

Abstract

BACKGROUND: The aim of this study was to investigate nipple-areola complex sensation at 48-month follow-up following superolateral pedicled reduction mammaplasty using the pressure-specified sensory device.
METHODS: Data regarding nipple-areola complex sensation for static and moving one- and two-point discrimination were collected from 30 active group hypertrophic-breasted patients undergoing superolateral pedicled reduction mammaplasty preoperatively, at 6 months, and at 48 months, and from a control group of 30 unoperated women with normal-sized breasts. Breast volume was assessed using the BREAST-V instrument.
RESULTS: For the nipple, static one-point discrimination showed that mean pressure thresholds for the active group at 48 months were 4.10 and 4.19 times higher than preoperatively and in the control group (p<0.001), respectively; moving one-point discrimination showed that mean pressure thresholds for the active group at 48 months were 4.08 and 3.23 times higher than preoperatively and in the control group (p<0.001), respectively. For the areola, static one-point discrimination showed that mean pressure thresholds in the active group at 48 months were 4.12 and 4.83 times higher than preoperatively and in the control group (p<0.001), respectively; moving one-point discrimination showed that mean pressure thresholds from the active group at 48 months were 4.56 and 4.46 times higher than preoperatively and in the control group (p<0.001), respectively.
CONCLUSIONS: Despite a slight worsening at 6 months after surgery, patients who had undergone superolateral pedicled reduction mammaplasty showed significant nipple-areola complex sensibility reduction at 48-month follow-up. Although the nipple-areola complex of hypertrophic-breasted patients was seen to be nonsignificantly less sensitive than normal-sized breasts, a significant decrease of sensation was observed following reduction mammaplasty. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.

Entities:  

Mesh:

Year:  2013        PMID: 24165625     DOI: 10.1097/PRS.0b013e3182a3bf05

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  6 in total

Review 1.  Anatomy of the nipple and breast ducts.

Authors:  Gustavo Zucca-Matthes; Cícero Urban; André Vallejo
Journal:  Gland Surg       Date:  2016-02

Review 2.  The altering in sensory sensitivity: a current issue of female breast surgery.

Authors:  Tong Zhu; Yi Jiang; Ting Liu; Jinqi Xue; Nan Niu; Jiawen Bu; Mingxin Liu; Caigang Liu; Xudong Zhu; Xi Gu
Journal:  Int J Med Sci       Date:  2022-05-16       Impact factor: 3.642

3.  Impact of Patient and Operative Factors on Nipple-Areola Complex Sensation after Bilateral Reduction Mammaplasty.

Authors:  Jesse I Payton; Jasson T Abraham; Matthew D Novak; Kendall P Hammonds; Andrew Altman
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-06-02

4.  Correction of Inverted Nipple Using Subcutaneous Turn-Over Flaps to Create a Tent Suspension-Like Effect.

Authors:  Hii-Sun Jeong; Hye-Kyung Lee
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

5.  Lumbar artery perforator (LAP) flap: a salvage tool for extended lumbo-sacral necrosis after bilateral internal iliac arteries embolization.

Authors:  Pietro Giovanni di Summa; Clara Schaffer; Patrice Zaugg; Olivier Bauquis; Wassim Raffoul
Journal:  Case Reports Plast Surg Hand Surg       Date:  2016-04-18

6.  Plantar pressure in diabetic peripheral neuropathy patients with active foot ulceration, previous ulceration and no history of ulceration: a meta-analysis of observational studies.

Authors:  Malindu Eranga Fernando; Robert George Crowther; Elise Pappas; Peter Anthony Lazzarini; Margaret Cunningham; Kunwarjit Singh Sangla; Petra Buttner; Jonathan Golledge
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.